Granulocyte macrophage colony-stimulating factor (GM-CSF; CSF2); GM-CSF receptor (CSF2RA; GMR; CD116) BriefCommunication Pages: 818 - 818
c-Myc (MYC); plasmacytoma variant translocation 1 oncogene (PVT1) BriefCommunication Pages: 823 - 823
Adenosine A2B receptor (ADORA2B ); kruppel-like factor 4 (KLF4; EZF) BriefCommunication Pages: 826 - 826
Aryl hydrocarbon receptor (AHR); indoleamine 2,3-dioxygenase 1 (IDO1) BriefCommunication Pages: 830 - 830
Assessing circulating donor cell-free DNA levels to predict heart transplant rejection BriefCommunication Pages: 839 - 839
DNA sequencing of drug-resistant mammalian cells and clustered, regularly interspaced short palindromic repeats (CRISPR)-Cas9 genome editing to identify drug targets BriefCommunication Pages: 840 - 840
Mouse model of Ewing's sarcoma with cell-specific expression of a transgenic Ewing sarcoma breakpoint region 1 (EWSR1; EWS)-Friend leukemia virus integration 1 (FLI1) fusion protein BriefCommunication Pages: 841 - 841
Zebrafish and cell culture models for arrhythmogenic cardiomyopathy BriefCommunication Pages: 842 - 842
A protocol to induce in vivo production of antigen-specific Treg cells BriefCommunication Pages: 844 - 844
Polar body transfer in oocytes for nuclear DNA replacement without mitochondrial DNA BriefCommunication Pages: 845 - 845
Noninvasive, two-photon fluorescence imaging to detect retinoid condensations in age-related macular degeneration (AMD) BriefCommunication Pages: 846 - 846
Cartilage oligomeric matrix protein (COMP) epitopes as markers of pathological joint degeneration BriefCommunication Pages: 847 - 847